Oramed Pharmaceuticals Inc. (ORMP): Revenue
Partial revenue. In this company's filings, net income for the year ended 2025-12-31 is larger than reported revenue. The revenue it tags covers only part of its income (banks and REITs often tag only fee income this way, leaving out interest or rent), so it is not the company's whole top line. Margins on it are not computed, and it is left out of revenue rankings.
$2.00M
Year ended 2025-12-31
-9.6%
3-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.00M | n/a | 2026-03-26, From 2025-01-01 |
| No annual figure between 2023-12-31 and 2025-12-31. | |||
| 2023-12-31 | $1.34M | -50.4% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $2.70M | n/a | 2024-03-06, From 2022-01-01 |
| No annual figure between 2021-08-31 and 2022-12-31. | |||
| 2021-08-31 | $2.70M | -0.3% | 2021-11-24, From 2020-09-01 |
| 2020-08-31 | $2.71M | +0.3% | 2021-11-24, From 2019-09-01 |
| 2019-08-31 | $2.70M | +10.4% | 2020-11-24, From 2018-09-01 |
| 2018-08-31 | $2.45M | -0.3% | 2019-11-27, From 2017-09-01 |
| 2017-08-31 | $2.46M | +283.2% | 2019-11-27, From 2016-09-01 |
| 2016-08-31 | $641.0K | n/a | 2018-11-28, From 2015-09-01 |